Review: Predictive and prognostic markers for epidermal growth factor receptor inhibitor therapy in non-small cell lung cancer

Bibliographic Details
Main Authors:	Nir Peled, Koichi Yoshida, Murry W. Wynes, Fred R. Hirsch
Format:	Article
Language:	English
Published:	SAGE Publishing 2009-11-01
Series:	Therapeutic Advances in Medical Oncology
Online Access:	https://doi.org/10.1177/1758834009347923

Angiogenesis and epidermal growth factor receptor inhibitors in non-small cell lung cancer
by: Giuliano Palumbo, et al.
Published: (2020-04-01)

Resistance mechanisms to epidermal growth factor receptor inhibitors in non-small cell lung cancer
by: Suresh Kumar Bondili, et al.
Published: (2020-01-01)

Prognostic value of epidermal growth factor receptor expression in operable non-small cell lung carcinoma
by: Seyhan Ekrem, et al.
Published: (2010-10-01)

Prognostic value of localization of epidermal growth factor receptor in lung adenocarcinoma
by: Jinn-Li Wang, et al.
Published: (2018-06-01)

Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
by: Yu-Mu Chen, et al.
Published: (2015-01-01)

Application of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor as the First-line Therapy in Patients with Advanced Non-small Cell Lung Cancer
by: Chunsun LI, et al.
Published: (2010-01-01)

Stratification of non-small cell lung cancer patients for therapy with epidermal growth factor receptor inhibitors: the EGFR fluorescence in situ hybridization assay
by: Varella-Garcia Marileila
Published: (2006-08-01)

Epidermal growth factor receptor inhibitors in non-small cell lung cancer: current status and future perspectives
by: Mauro Zükin
Published: (2012-04-01)

Expression of Epidermal Growth Factor Receptor and the association with Demographic and Prognostic Factors in Patients with Non-small Cell Lung Cancer
by: Reza Basiri, et al.
Published: (2015-06-01)

Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)
by: Wolfgang M. Brueckl, et al.
Published: (2020-12-01)

The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer
by: Shih-Chieh Chang, et al.
Published: (2011-06-01)

The mechanisms between cigarette smoking and desensitizes epidermal growth factor receptor - expressing non-small cell lung cancer to epidermal growth factor receptor - tyrosine kinase inhibitors
by: Chih-Yen Tu, et al.
Published: (2018)

Three generations of epidermal growth factor receptor tyrosine kinase inhibitors developed to revolutionize the therapy of lung cancer
by: Zhang H
Published: (2016-11-01)

The roles of epidermal growth factor receptor (EGFR) inhibitors in the management of lung cancer
by: Ashwaq Al Olayan, et al.
Published: (2012-12-01)

A novel epidermal growth factor receptor inhibitor for treating lung cancer
by: Jiansheng Gao, et al.
Published: (2017-03-01)

Feasibility of tissue re-biopsy in non-small cell lung cancers resistant to previous epidermal growth factor receptor tyrosine kinase inhibitor therapies
by: Sakurako Uozu, et al.
Published: (2017-12-01)

Prognostic role of epidermal growth factor receptors’ expression in patients with i-ii stage of non-small cell lung cancer
by: A.P. Kolesnik, et al.
Published: (2013-08-01)

Immunotherapy combined with epidermal growth factor receptor-tyrosine kinase inhibitors in non-small-cell lung cancer treatment
by: Liang H, et al.
Published: (2018-09-01)

Retreatment with Epidermal Growth Factor Receptor Inhibitor After Initial Failure in Advanced Non-small Cell Lung Cancer
by: Tongtong AN, et al.
Published: (2011-03-01)

Effectiveness of Tyrosine Kinase Inhibitors on Uncommon Epidermal Growth Factor  Receptor Mutations in Non-small Cell Lung Cancer
by: Xue YANG, et al.
Published: (2015-08-01)

Epidermal growth factor receptor tyrosine kinase inhibitors with conventional chemotherapy for the treatment of non-small cell lung cancer
by: Gao Y, et al.
Published: (2015-12-01)

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Elderly Patients with Advanced Non-Small Cell Lung Cancer
by: F. Meriggi, et al.
Published: (2010-01-01)

ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.
by: Takeshi Yoshida, et al.
Published: (2016-01-01)

Epidermal growth factor receptor-mutant non-small cell lung Cancer and Choroidal metastases: long-term outcome and response to epidermal growth factor receptor tyrosine kinase inhibitors
by: Clémentine Bouchez, et al.
Published: (2020-12-01)

Early radiographic response to epidermal growth factor receptor-tyrosine kinase inhibitor in non-small cell lung cancer patients with epidermal growth factor receptor mutations: A prospective study
by: John WC Chang, et al.
Published: (2015-06-01)

Epidermal growth factor receptor tyrosine kinase defines critical prognostic genes of stage I lung adenocarcinoma.
by: Mai Yamauchi, et al.
Published: (2012-01-01)

Inferior outcome of bone metastasis in non-small-cell-lung-cancer patients treated with epidermal growth factor receptor inhibitors
by: Yue-Yun Chen, et al.
Published: (2021-08-01)

A Review of Epidermal Growth Factor Receptor/HER2 Inhibitors in the Treatment of Patients with Non–Small-Cell Lung Cancer
by: Ramaswamy GOVINDAN
Published: (2010-04-01)

Research Progress on Resistance Mechanisms of Epidermal Growth Factor Receptor  Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer
by: Yuan LI, et al.
Published: (2012-02-01)

Third-Generation Tyrosine Kinase Inhibitors Targeting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer
by: Tristan A. Barnes, et al.
Published: (2017-05-01)

Mechanisms of Resistance to the Third-generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer
by: Lianfang NI, et al.
Published: (2018-02-01)

The role of epidermal growth factor receptor in non-small cell lung cancer
by: Ayşe Feyda Nursal
Published: (2015-03-01)

Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types
by: Sojung Park, et al.
Published: (2021-01-01)

The Efficacy and Safety of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Thymosin in Advanced Non-Small Cell Lung Cancer Patients Harboring Active Epidermal Growth Factor Receptor Mutations
by: Yongdong Feng, et al.
Published: (2021-05-01)

Meta-Analysis of Aidi Injection and First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy in Treating Advanced Non-Small Cell Lung Cancer
by: Na Xiao MD, et al.
Published: (2021-04-01)

The Evolving Role of Maintenance Therapy Using Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) in the Management of Advanced Non-Small-Cell Lung Cancer
by: Chao H. Huang, et al.
Published: (2012-03-01)

The Evolving Role of Maintenance Therapy Using Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) in the Management of Advanced Non-Small-Cell Lung Cancer
by: Chao H. Huang, et al.
Published: (2012-01-01)

Metastatic Squamous Cell Carcinoma from Lung Adenocarcinoma after Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy
by: Hyung Kyu Park, et al.
Published: (2017-07-01)

Research Progress of Epidermal Growth Factor Receptor and Molecular-Targeted Therapy in Treatment of Non-Small Cell Lung Cancer
by: Xiaoyou Li, et al.
Published: (2014-03-01)

Prognostic value of epidermal growth factor receptor mutations in resected non-small cell lung cancer: a systematic review with meta-analysis.
by: Zhixuan Zhang, et al.
Published: (2014-01-01)

Review: Predictive and prognostic markers for epidermal growth factor receptor inhibitor therapy in non-small cell lung cancer

Similar Items

Similar Items